Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Medicina|December 18, 2010
[Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients]Ana I González, Fernando Brites, Alicia Elbert, et al.
Steroids|April 2, 2014
Adrenocortical function in hypotensive patients with end stage renal diseaseAlejandro L Arregger, Estela M L Cardoso, Alfredo Zucchini, et al.
Diabetes Research and Clinical Practice|June 30, 2006
Chronic renal failure in diabetic patients increases lipid risk factors for atherosclerosisFernando D Brites, Karina M Fernández, Julián Verona, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2010
Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal diseaseEstela M L Cardoso, Liliana N Contreras, Elida G Tumilasci, et al.
Clinical Biochemistry|December 31, 2011
HDL-associated enzymes and proteins in hemodialysis patientsLeonardo D Cacciagiú, Ana I González, Leonardo Gomez Rosso, et al.
Metabolic Syndrome and Related Disorders|March 8, 2014
Do insulin resistance conditions further impair the lipid and inflammatory profile in end-stage renal disease patients on hemodialysis?Leonardo Cacciagiú, Ana I González, Alicia Elbert, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2012
Endothelial lipase activity predicts high-density lipoprotein catabolism in hemodialysis: novel phospholipase assay in postheparin human plasmaVeronica Miksztowicz, Mary G McCoy, Laura Schreier, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|February 14, 2016
Glycaemic changes in patients with chronic kidney diseaseGuillermo De'Marziani, Gervasio Soler Pujol, Liliana Miriam Obregón, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping ReviewJorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert, et al.
Pageof 2